CClinicalTrials.gg
Status unknownNCT03543293Updated Jun 1, 2018

Imaging Perilymphatic Fistulas After Barotrauma

An observational study in Perilymphatic Fistulas, sponsored by University Hospital, Strasbourg, France. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-06-01.

Sponsored by University Hospital, Strasbourg, France · Observational

The sponsor has not verified this record recently (last verified Feb 2018), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
101
Ages
18 Years and older
Sex
All
01

Study summary

Our objective is to validate the CT / MRI combination of non-injected rock for the rapid positive diagnosis of perilymphatic fistulas.

02

Conditions studied

  • Perilymphatic Fistulas

Browse trials for

Keywords

  • perilymphatic fistulas
  • magnetic resonance imaging (MRI)
  • surgery
  • round window
  • vertigo
  • tinnitus
  • cophosis
03

In context

Fistula

731 studies on the registry are indexed under Fistula; 103 are open to participants now.

This study's planned enrollment of 101 is close to the median of 100 across 221 observational studies indexed under Fistula.

Browse Fistula studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 966 studies on the registry; 342 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patient having undergone a rock scan or MRI of the middle ear at the Strasbourg University Hospital with surgical confirmation of the diagnosis (or reversal)

Inclusion criteria

  • Age greater than or equal to 18
  • Clinical suspicion of perilymphatic fistula
  • Patient having undergone a rock scan or MRI of the middle ear at the Strasbourg University Hospital with surgical confirmation of the diagnosis (or reversal)

Exclusion criteria

Exclusion Criteria:

  • Refusal of the patient to participate in the study
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
101 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Diagnosis of perilymphatic fistula

    Time frame: 1 hour after surgery

07

Study locations

1 of 1 sites recruiting
  • Service Imagerie 1
    Strasbourg, 67098, France
    • Francis VEILLON, MD, PhD · Contact · 33 3 88 12 78 65
    • Aïna VENKATASAMY, MD · Contact · aina.venkatasamy@chru-strasbourg.fr · 33 3 88 12 78 65
    • Francis VEILLON, MD, PhD · Principal investigator
    • Aïna VENKATASAMY, MD · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 1, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03543293
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
Jun 1, 2018
Start date
Feb 20, 2018
Primary completion
Feb 2019 (estimated)
Completion
Feb 2019 (estimated)
Last update
Jun 1, 2018

Study contacts

Francis VEILLON, MD, PhD
Contact
Francis.veillon@chru-strasbourg.fr
33 3 88 12 78 65
Aïna VENKATASAMY, MD
Contact
aina.venkatasamy@chru-strasbourg.fr
33 3 88 12 78 65
Francis VEILLON, MD, PhD
study director · University Hospital, Strasbourg, France

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion